Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model

2021; American Society for Microbiology; Volume: 6; Issue: 1 Linguagem: Inglês

10.1128/msphere.00927-20

ISSN

2379-5042

Autores

Christina L. Hutson, Ashley V. Kondas, Matthew R. Mauldin, Jeffrey B. Doty, Irma M. Grossi, Clint N. Morgan, Sharon Dietz Ostergaard, Christine M. Hughes, Yoshinori Nakazawa, C. Kling, Brock E. Martin, James A. Ellison, Darin D. Carroll, Nadia Gallardo‐Romero, Victoria A. Olson,

Tópico(s)

Bacillus and Francisella bacterial research

Resumo

Preparedness activities against highly transmissible viruses with high mortality rates have been highlighted during the ongoing coronavirus disease 2019 (COVID-19) pandemic. Smallpox, caused by variola virus (VARV) infection, is highly transmissible, with an estimated 30% mortality.

Referência(s)